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Abstract
Study Design: Retrospective cohort study.
Objectives: Describe the rate and risk factors for venous thromboembolic events (VTEs; defined as deep venous thrombosis
[DVT] and/or pulmonary embolism [PE]) in adult spinal deformity (ASD) surgery.
Methods: ASD patients with VTE were identified in a prospective, multicenter database. Complications, revision, and mortality
rate were examined. Patient demographics, operative details, and radiographic and clinical outcomes were compared with a non-
VTE group. Multivariate binary regression model was used to identify predictors of VTE.
Results: A total of 737 patients were identified, 32 (4.3%) had VTE (DVT ¼ 14; PE ¼ 18). At baseline, VTE patients
were less likely to be employed in jobs requiring physical labor (59.4% vs 79.7%, P < .01) and more likely to have
osteoporosis (29% vs 15.1%, P ¼ .037) and liver disease (6.5% vs 1.4%, P ¼ .027). Patients with VTE had a larger
preoperative sagittal vertical axis (SVA; 93mm vs 55mm, P < .01) and underwent larger SVA corrections. VTE was
associated with a combined anterior/posterior approach (45% vs 25%, P ¼ .028). VTE patients had a longer hospital stay
(10 vs 7 days, P < .05) and higher mortality rate (6.3% vs 0.7%, P < .01). Multivariate analysis demonstrated osteo-
porosis, lack of physical labor, and increased SVA correction were independent predictors of VTE (r2 ¼ .11, area under
the curve ¼ 0.74, P < .05).
Conclusions: The incidence of VTE in ASD is 4.3% with a DVT rate of 1.9% and PE rate of 2.4%. Osteoporosis, lack of physical
labor, and increased SVA correction were independent predictors of VTE. Patients with VTE had a higher mortality rate com-
pared with non-VTE patients.
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Introduction
Venous thromboembolic events (VTEs), which include deep
vein thrombosis (DVT) and pulmonary embolism (PE), are
major and potentially life-threatening complications that have
been labelled as “reasonably preventable” if evidence-based
guidelines are utilized.1 In 2009, the Centers for Medicare &
Medicaid Services designated VTEs after total knee and total
hip replacements a nonreimbursable complication; this man-
date was initiated to accelerate improvement in the quality of
care and adoption of best practices across the country.1 Given
the attention paid to VTE complications by regulatory agencies
and the associated potential for morbidity, it is important for
spine surgeons to be aware of the rate of VTEs and the risk
factors for this complication.
Recently, several authors have attempted to define the rate
of VTE following surgery. Reported rates for VTEs following
spine surgery have varied widely, ranging from 0.40% to
22%.2-10 There are a number of reasons for this variation. Many
of these studies focus on all elective spine procedures4,5,9 or are
drawn from large national- and state-level databases.2,6,7,11,12
As a result, these studies encapsulate a diverse array of spinal
procedures that have a widely varying risk of DVT. Another
reason for discrepancy is the definition of VTE: some studies
focus exclusively on PE,8 others on symptomatic VTE,2,6,11,12
and others on screening ultrasonography.5 Data on the rates
of VTE in an adult spinal deformity (ASD) population,
however, remains limited. While some authors have a subset
of patients with “long fusions” or “thoracolumbar fusions”
in their cohorts,2,4,10 the definition of these groups is often
vague and makes it difficult to infer the rates of VTE in
patients with ASD.
The purpose of this study is to report the incidence and risk
factors for clinically significant VTE (DVT and/or PE) in
patients undergoing surgery for ASD. Identifying those
patients at highest risk can be valuable information for pre-
vention and for the judicious use of prophylactic anticoagula-
tion in a patient population where anticoagulation use may not
be desirable.
Methods
This study was a retrospective review of a prospectively col-
lected multicenter ASD database maintained by the Interna-
tional Spine Study Group. After institutional review board
approval at each site, patients from 11 sites were enrolled into
a prospective database of operative and nonoperative ASD
patients. Adult patients (age >18 years) were included if one
or more of the following radiographic criteria were met: cor-
onal Cobb angle >20, sagittal vertical axis (SVA) >5 cm, pel-
vic tilt >25, or thoracic kyphosis >60. Exclusion criteria
included neuromuscular scoliosis, infection, and malignancy.
Only patients from the operative cohort were considered for
this study.
Patients were separated into 2 groups: (1) patients with VTE
and (2) patients without VTE (non-VTE). VTE was defined as
DVT or PE diagnosed during the patients’ postoperative course
at any time point. The diagnosis of VTE was recorded after a
review of the patients’ hospital course and clinic notes. These
reviews were performed at each follow-up interval, that is, at
6 weeks, 1 year, 2 years, and so on. There were no standardized
protocols to diagnose VTE and no screening ultrasounds or
computed tomography scans performed. Data on the type of
VTE prophylaxis provided was not available.
Demographic data collected included age, gender, race, and
body mass index (BMI). Data on comorbidities was also
recorded along with American Society of Anesthesiologists
(ASA) classification and Charlson Comorbidity Index (CCI).
Full-length standing spine radiographs were used to assess
patients’ deformity, and each radiograph was analyzed and
verified by a centralized research team. Operative data col-
lected included estimated blood loss (EBL), operative time,
and intraoperative case details (such as osteotomy type, decom-
pressions, anti-fibrinolytic use, etc). Postoperative variables
such as length of stay, intensive care unit (ICU) stay, and
complication data were also collected for all patients.
Follow-up time points were at 6 weeks, 1 year, 2 years, and
annually afterward. Reporting of complications included the
complication type (eg, neurologic, infectious, etc), the compli-
cation time (intraoperative vs postoperative), and complication
severity (major vs minor). Major intraoperative complications
consisted of cardiac arrest, spinal cord injury, death, nerve root
injury, optical deficit, vessel and/or organ injury, blood loss
>4 L, pneumothorax, and having an unplanned staged surgery.
Major postoperative complications were defined as bowel
and/or bladder deficit, death, deep vein thrombosis, deep infec-
tion, motor deficit, myocardial infarction, optical deficit, pneu-
monia, pulmonary embolism, reintubation, sepsis, stroke, acute
respiratory distress, pancreatitis, tracheostomy, unplanned
return to the operating room, and arrhythmia. Last, Health-
related quality of life (HRQOL) data was collected. This
included the Oswestry Disability Index (ODI), 36-Item Short-
Form Health Survey (SF-36; physical component score [PCS]
and mental component score [MCS]), and the Scoliosis
Research Society-22r questionnaire (SRS; subdomains: activ-
ity, pain, satisfaction, mental, appearance, and total).13-15
Statistical Analysis
A Shapiro-Wilk test of normality showed that the distribution
of demographic and radiographic variables in the VTE and
non-VTE groups was nonnormal (P < .05). As a result, an
independent samples Mann-Whitney U test was used to com-
pare continuous variables in the VTE and non-VTE groups. A
w2 test was used to compare categorical variables. Once risk
factors were identified, a multivariate binary logistic regression
was performed with VTE as the dependent variable. Since this
was an exploratory model, all variables with P < .1 were
included in the model. Area under the curve (receiver operating
characteristic) was used to measure the accuracy and the ability
of the predictor to discriminate between patients with or with-
out complications.16 SPSS Statistics version 23.0 (IBM Corp,
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Armonk, NY) was used to perform all the analysis. Level of
significance was set to P value <.05 for all tests.
Results
Overview
A total of 737 patients with 6-week follow-up were identified
in the database. Out of the 737 patients, 450 were more than
2 years from their surgery and were eligible for 2-year
follow-up. Of this subset, 369 (82.0%) had data available
for analysis. The mean age was of 58.2 + 14.9 years with
565 (76.7%) females and 172 (23.3%) males. Average BMI
was 27.5+ 6. The rate of VTE in this patient population was
4.3% (n¼ 32). Of patients with VTE, 14 had a DVT (1.9%) and
18 had a PE (2.4%). Of the 32 cases of VTE, 30/32 (93.8%)
were identified postoperatively. Two cases of PE (2/32, 6.2%)
were identified intraoperatively. VTE prevalence ranged from
1% to 9.5% among individual centers (P ¼ .128) and 2.0% to
7.9% in individual calendar years (P ¼ .381). Two patients
with VTE died during the follow-up period (2/32, 6.3%); the
cause of death was not recorded in the database.
Demographic and Radiographic Variables
Our univariate analysis revealed no difference in age between
the VTE and non-VTE groups (VTE ¼ 64.2 vs non-VTE ¼ 61,
P ¼ .063; Table 1). Similarly, there was no difference between
groups in BMI (P¼ .260), race (P¼ .820), CCI (P¼ .274), and
ASA (P ¼ .667). Patients with VTE were less likely to be
involved in physical labor jobs (odds ratio [OR] ¼ 0.4, 95%
confidence interval [CI] ¼ 0.2-0.8, P ¼ .006). When specific
comorbidities were compared, patients with VTE were noted to
have higher rates of liver disease (OR ¼ 5.0, 95% CI ¼
1.03-24.2, P ¼ .027) and osteoporosis (OR ¼ 2.3, 95% CI ¼
1.02-5.1, P ¼ .037; Table 2). There was no difference between
groups with regard to rate of smoking (P ¼ .612), cancer (P ¼
.795), and clotting disorders (P ¼ .706), although these con-
clusions are limited by the relatively low number of smokers
and patients with cancers and clotting disorders.
Patients with VTE had a greater SVA (92.5mm vs 55mm,
P ¼ .004) and larger upper thoracic (28.0 vs 18.0, P ¼ .042)
and thoracolumbar (39.0 vs 30.0, P¼ .031) coronal curves at
baseline (Table 3). Patients with VTE had a greater SVA cor-
rection at 6 weeks compared with the non-VTE group (72mm
vs 31mm, P ¼ .004). At 2-year follow-up, there were no sig-
nificant radiographic differences between the groups.
Intraoperative variables
VTE and non-VTE patients had a similar operating room time
(413 vs 369 minutes, P ¼ .306), EBL (1900 vs 1300mL,
P ¼ .271), number of levels fused (14.1 vs 14.0, P ¼ .683),
and interbody fusion (OR ¼ 2.0, 95% CI ¼ 0.9-4.6, P ¼ .084;
Table 4). Three-column osteotomies did not increase the risk of
VTE (OR ¼ 0.9, 95% CI ¼ 0.3-2.3, P ¼ .760 for PSO, and
OR ¼ 1.3, 95% CI¼ 0.3-5.7, P¼ .714 for VCR). Patients with
a VTE were more likely to have undergone a same-day com-
bined (anterior-posterior) surgical approach (OR ¼ 2.4, 95%
CI ¼ 1.1-4.9, P ¼ .018) but not a staged anterior-posterior
procedure (OR ¼ 1.8, 95% CI ¼ 0.8-4.0, P ¼ .173). Anti-
fibrinolytic drugs (including aminocaproic acid and tranexamic
acid) were used at similar rates in both groups (OR ¼ 0.7, 95%
CI ¼ 0.3-1.3, P ¼ .245).
Table 1. Comparisons of Demographics Between VTE and Non-VTE Groupsa.
VTE (N ¼ 32) Non-VTE (N ¼ 705) OR (95% CI) P Value
Age 64 (41-84) 61 (18-86) .063
BMI 25.1 (16.8-37.3) 26.7 (16.5-65.9) .260
CCI 2 (0-5) 1 (0-8) .274
Gender (n ¼ 725) .710
Male 6 (19.4%) 154 (22.2%)
Female 25 (80.6%) 540 (77.8%)
Race (n ¼ 684) .820
Asian 0 (0%) 10 (1.5%)
Black 2 (7.1%) 26 (4%)
Hispanic 1 (3.6%) 16 (2.4%)
White 25 (89.3%) 597 (91%)
Other 0 (0%) 7 (1.1%)
ASA (n ¼ 695) .667
I 3 (10%) 48 (7.2%)
II 13 (43.3%) 331 (49.8%)
III 13 (43.3%) 278 (41.8%)
IV 1 (3.3%) 8 (1.2%)
Employed in physical labor 19 (59.4%) 562 (79.7%) 0.4 (0.2-0.8) .006
History of prior spine surgery 11 (35.5%) 338 (49.5%) 0.6 (0.3-1.2) .127
Abbreviations: VTE, venous thromboembolic event; OR, odds ratio; CI, confidence interval; BMI, body mass index; CCI, Charlson Comorbidity Index; ASA,
American Society of Anesthesiologists classification.
aAge, BMI, and CCI are reported as median (minimum–maximum).
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Complications
VTE patients had a higher rate of intra- and perioperative com-
plications compared with the non-VTE group. However, there
was no difference in the rate of postoperative complications
between the groups (OR ¼ 1.5, 95% CI ¼ 0.7-3.2, P ¼ .247).
VTE patients had a longer length of stay (10 vs 7 days, P < .001;
Table 5) and a higher rate of mortality compared with non-VTE
patients (OR¼ 9.3, 95%CI¼ 1.7-50.1,P¼ .002).Unfortunately,
wewere unable to determine the cause ofmortality in these cases.
HRQOL Scores
Patients with VTE were more likely to have a lower SF-36 PCS
score at baseline (27 vs 31, P ¼ .011; Table 6). However, there
were no other differences in HRQOL scores at baseline and at
final follow-up, and there were no differences in HRQOL
scores between groups.
Independent Predictors of VTE
Our regression model adjusted for all variables with P < .1,
namely, age, history of physical labor, depression, liver
diseases, osteoporosis, preoperative SVA, and SVA correction.
All 737 patients were included. Increased SVA correction
(OR ¼ 1.007 per mm of correction, 95% CI ¼ 1.001-1.013,
P ¼ .015), osteoporosis (OR ¼ 2.68, 95% CI ¼ 1.07-6.7,
P ¼ .035), and lack of physical labor at baseline (OR ¼ 3.0,
95% CI ¼ 1.2-7.3, P ¼ .002) all increased the risk of VTE. For
this model, the r2 was .113, and the area under the curve was
0.740 with P ¼ .050.
Discussion
In this review of a multicenter database, we report a 4.3% rate
of clinically significant VTEs among all patients undergoing
surgery for ASD. The rate of DVT was 1.9%, while the rate for
PE was 2.4%. Our multivariate model found that increased
SVA correction, a diagnosis of osteoporosis, and a lack of
physical labor at baseline were independent predictors of an
increased VTE risk. We also found that patients with VTE were
more likely to have a longer length of stay in the hospital
(10 days vs 7 days) and had a higher mortality rate (6.3% vs
0.7%). While we do not know the cause of mortality in all these
cases, these findings may be of value to deformity surgeons
Table 3. Radiographic Comparisons Between VTE and Non-VTE Patients at Immediate Postoperative Visita.
Radiographic Parameters
Preoperative 2-Year Follow-up
VTE (N ¼ 32) Non-VTE (N ¼ 705) P Value VTE (N ¼ 13) Non-VTE (N ¼ 356) P Value
PI () 55 (24 to 82) 54 (12 to 100) .766 50 (24 to 83) 54 (14 to 90) .985
PT () 24 (6 to 44) 23 (13 to 68) .787 26 (2 to 32) 21 (6 to 62) .582
LL () 38 (14 to 70) 39 (28 to 100) .862 54.5 (20 to 73) 52 (6 to 93) .703
PI-LL () 15 (22 to 58) 16 (41 to 84) .949 0.5 (30 to 28) 4 (36 to 73) .917
TK () 36 (85 to 1) 35 (121 to 24) .458 57.5 (80 to 27) 48 (101 to 0) .137
T1PA () 26.5 (10 to 47) 22 (9 to 73) .169 19 (1 to 37) 16 (11 to 63) .349
SVA (mm) 92.5 (7 to 250) 55 (89 to 326) .004 59.5 (42 to 169) 26 (109 to 238) .162
Upper thoracic Cobb () 28 (4 to 78) 18 (4 to 63) .042 28 (4 to 78) 18 (4 to 63) .538
Thoracic Cobb () 27 (5 to 82) 24 (2 to 91) .436 27 (5 to 82) 24 (2 to 91) .770
Thoracolumbar Cobb () 39.5 (9 to 98) 30 (0 to 120) .031 39.5 (9 to 98) 30 (0 to 120) .508
Lumbar Cobb () 22 (7 to 57) 22 (2 to 74) .844 22 (7 to 57) 22 (2 to 74) .581
Abbreviations: VTE, venous thromboembolic event; PI, pelvic incidence; PT, pelvic tilt; LL, lumbar lordosis; TK, thoracic kyphosis; SVA, sagittal vertical axis.
Table 2. Comparisons of Percentage of Patients With Specific Comorbidities Between VTE and Non-VTE Groups.
Preoperative Comorbidity VTE (N ¼ 32), n (%) Non-VTE (N ¼ 705), n (%) OR (95% CI) P Value
Anemia 2 (6.5%) 69 (10.4%) 0.6 (0.1-2.5) .476
Clotting disorders 1 (3.2%) 31 (4.7%) 0.7 (0.1-5.1) .706
Cancer 3 (9.7%) 74 (11.2%) 0.9 (0.3-2.9) .795
Depression 4 (12.9%) 181 (27.3%) 0.4 (0.1-1.1) .076
Diabetes 0 (0%) 53 (8%) — .101
Heart disease 2 (6.5%) 70 (10.6%) 0.6 (0.1-2.5) .462
Hypertension 10 (32.3%) 249 (37.6%) 0.8 (0.4-1.7) .547
Kidney disease 0 (0%) 19 (2.9%) — .339
Liver disease 2 (6.5%) 9 (1.4%) 5.0 (1.03-24.2) .027
Lung disease 2 (6.5%) 36 (5.4%) 1.2 (0.3-5.2) .809
Osteoporosis 9 (29%) 100 (15.1%) 2.3 (1.02-5.1) .037
Smoking 3 (9.4%) 46 (7%) 1.4 (0.4-4.7) .612
Abbreviations: VTE, venous thromboembolic event; OR, odds ratio; CI, confidence interval.
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when discussing the risks and benefits of surgery and, in par-
ticular, discussing the risk of complications with patients.
Our reported rate of VTE is higher than the overall rates
reported by other series of spine surgery patients.2,4,9 This
higher rate of VTE in our cohort is not surprising as the pro-
cedures performed in this cohort are technically demanding,
requiring long operative times (average operative time time
was >6 hours) with lengthy hospital stays (average hospital
Table 5. Comparison of Complications Between the VTE and Non-VTE Groupsa.
VTE (N ¼ 32) Non-VTE (N ¼ 705) OR (95% CI) P Value
Number of complications (any) 2 (1-9) 1 (0-9) <.001
Intraoperative complication 14 (43.8%) 186 (26.4%) 2.2 (1.1-4.5) .031
Perioperative complications 28 (87.5%) 239 (33.9%) 13.6 (4.7-39.4) <.001
Postoperative complications 13 (40.6%) 218 (30.9%) 1.5 (0.7-3.2) .247
Revision surgery 10 (31.3%) 143 (20.3%) 1.8 (0.8-3.9) .135
Death 2 (6.3%) 5 (0.7%) 9.3 (1.7-50.1) .002
Abbreviations: VTE, venous thromboembolic event; OR, odds ratio; CI, confidence interval.
aThe number of complications is reported as range (minimum–maximum).
Table 6. Baseline HRQOL and 2-Year Outcomes for the VTE and Non-VTE Groups.
HRQOL Outcomes
Preoperative 2-Year Follow-up
VTE (N ¼ 32) Non-VTE (N ¼ 705) P Value VTE (N ¼ 13) Non-VTE (N ¼ 356) P Value
ODI 44 (18-86) 46 (0-92) .571 38 (0-66) 26 (0-82) .629
SF36-PCS 27 (13-42) 31 (9-65) .011 35 (23-54) 40 (13-65) .660
SF36-MCS 49 (11-74) 47 (8-73) .977 58 (29-65) 53 (11-71) .461
SRS Pain 2 (1-4) 2 (1-5) .456 4 (2-5) 3 (1-5) .585
SRS Function 3 (1-4) 3 (1-5) .148 4 (2-5) 4 (1-5) .816
SRS Self-Image 2 (1-3) 2 (1-5) .080 4 (2-5) 4 (1-5) .933
SRS Mental Health 4 (1-5) 3 (1-5) .666 4 (3-5) 4 (1-5) .635
SRS Satisfaction 2 (1-4) 2 (1-5) .051 4 (2-5) 4 (1-5) .621
SRS Total 3 (1-4) 3 (1-5) .119 3 (2-5) 4 (2-5) .601
Abbreviations: HRQOL, health-related quality of life; VTE, venous thromboembolic event; ODI, Oswestry Disability Index; SF-36, 36-item Short-Form Health
Survey; PCS, Physical Component Score; MCS, mental component score; SRS, Scoliosis Research Society-22r questionnaire.
Table 4. Comparison of Surgical Parameters Between VTE and Non-VTE Groupsa.
VTE (N ¼ 32) Non-VTE (N ¼ 705) OR (95% CI) P Value
Operating room time (minutes) 413 (120-716) 369 (22-836) .306
EBL (mL) 1900 (50-5500) 1300 (20-12 200) .271
Approach .028
Anterior only 1 (3.1%) 6 (0.9%)
Posterior only 17 (53.1%) 515 (73.5%)
Combined (anterior-posterior) 14 (43.8%) 180 (25.7%) 2.4 (1.1-4.9) .018
Interbody fusion 24 (75%) 417 (59.7%) 2.0 (0.9-4.6) .084
Decompression 20 (64.5%) 426 (61.2%) 1.2 (0.5-2.4) .711
Osteotomy (any) 26 (81.3%) 480 (69.1%) 1.9 (0.8-4.8) .143
SPO 21 (65.6%) 364 (51.6%) 1.8 (0.9-3.8) .121
PSO 5 (15.6%) 125 (17.7%) 0.9 (0.3-2.3) .760
VCR 2 (6.3%) 34 (4.8%) 1.3 (0.3-5.7) .714
Antifibrinolytic use (any) 15 (48.4%) 400 (58.9%) 0.7 (0.3-1.3) .245
Amicar 7 (46.7%) 207 (51.8%)
Tranexamic acid 7 (46.7%) 182 (45.5%)
Other 1 (6.7%) 11 (2.8%)
Staged procedure 8 (25%) 112 (15.9%) 1.8 (0.8-4.0) .173
Length of stay (days) 10 (4-49) 7 (0-55) <.001
SICU stay 23 (74.2%) 482 (70.8%) 1.2 (0.5-2.7) .682
Abbreviations: VTE, venous thromboembolic event; OR, odds ratio; CI, confidence interval; EBL, estimated blood loss; SPO, Smith-Petersen osteotomy; PSO,
pedicle subtraction osteotomy; VCR, vertebral column resection; SICU, surgical intensive care unit.
aMedian and (minimum–maximum) values are reported for continuous variables.
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stay was >7 days). Indeed, the overall rate of VTE in this study
might be understated because up to 40% of VTE cases are
diagnosed at hospitals that are different from the institution
where a patient’s surgery was performed.2 In addition, not all
patients are routinely screened for VTEs and our incidence
represents those patients who were symptomatic and subse-
quently worked-up for VTEs. This fact may introduce a report-
ing bias and may explain why our reported rate of DVT (1.9%)
was lower than our reported rate for PE (2.4%). The screening
process can also falsely report the incidence of DVT relative to
PE since routine computed tomography to rule out PE does not
always include a run through the lower extremities to rule out
DVT. The relevance of this is uncertain, since lower extremity
DVTs have not been shown to embolize proximally to become
a PE, while more proximal DVTs in the proximal thigh and
pelvis have been associated with PEs.17,18
In our univariate analysis of operative variables, only one
(anterior-posterior approach) was associated with an
increased risk for VTE. This finding has been previously
identified in the literature.2,9,18 We showed that the use of
anti-fibrinolytic agents did not increase the risk of VTE in
our cohort. The use of these agents has been shown to
decrease blood loss in several areas of orthopedics, and our
data suggests that they may be used safely in carefully
selected ASD patients as long as relevant comorbidities such
as a history of stroke, PE, tumors, and cardiac stenting pro-
cedures are considered. Our data also found no increase in the
risk of VTE with osteotomies in deformity correction; how-
ever, this finding must be interpreted with caution given the
relatively low numbers of VTE in patients with 3-column
osteotomies and the fact that increased SVA correction was
found to be a risk factor for VTE in a multivariate analysis.
A connection between SVA correction and VTE has not
previously been reported in the literature; it is impossible to
study in large database trials and is likely not routinely mea-
sured in cases with degenerative pathology. Unfortunately, the
retrospective nature of this study makes it difficult to determine
exactly why SVA correction might increase risk of VTE. It is
possible that patients with larger deformity corrections are
undergoing more significant operative procedures and are
slower to mobilize postoperatively. Another possibility is that
correction of kyphotic deformities leads to traction along the
anterior spinal cord, leading to stretching and epithelial injury
of the vena cava, which, in turn, increases the risk of VTE. This
finding is of considerable clinical importance. There is data
now to suggest that increased SVA correction predisposes to
complications such as proximal junctional kyphosis.19 There is
also greater attention being paid to age-based correction tar-
gets, with the recognition that larger SVAs might be normal in
older patients.20,21 Our study provides adds to this body of
work and suggests that surgeons must be judicious when plan-
ning their corrections and must take age, patient function, and
the risk of complications into account when doing so.
In addition to operative variables, our analysis identified 2
preoperative variables that were independent predictors of
VTE risk: the lack of physical labor at baseline and
osteoporosis. These are also unique findings that have not pre-
viously been reported in the literature. The finding of osteo-
porosis, in particular, is of particular interest to deformity
surgeons given the older, female-predominant patient popula-
tion encountered in the field (and reported on in this article).
The treatment of osteoporosis with selective estrogen receptor
modulators may produce a hypercoagulable state that has been
shown to increase the risk of VTE.22-24 Furthermore, it is pos-
sible that osteoporosis is a general marker of frailty and immo-
bility as is the lack of physical labor at baseline. A lack of
physical activity might result in compromised venous circula-
tion and increased venous stasis.
Last, our results suggest that VTE may have a significant
economic impact. Patients diagnosed with VTE tended to have
a longer hospital stay and higher mortality rates than the non-
VTE cohort. While we were unable to determine the cause of
mortality and are unable to conclude if VTE was the cause of
the longer hospital stay, this finding brings attention to the
possible need for prophylaxis regimens in those with a pro-
longed length of stay. A targeted VTE prophylaxis regimen for
these patients might be an area for further research.
In addition to the retrospective study design, our conclu-
sions are limited by the fact that VTE remains a relatively rare
phenomenon in spine surgery. Even in a series of 737 patients,
we only had 32 cases of VTE.
Additionally, the multicenter aspect of this protocol and the
staged follow-up makes it difficult to accurately determine the
type of VTE prophylaxis administered (pneumatic compres-
sion boots, aspirin, etc) and the clinical context in which VTE
was diagnosed. It is possible that VTE was diagnosed as an
incidental finding in some cases. However, we believe this is
unlikely as the tests to diagnose VTE are seldom ordered in our
clinical practice unless there is a high level of clinical suspi-
cion. Additionally, we could not determine the timing of VTE
following surgery. Despite these limitations, to our knowledge,
this is the largest series of deformity patients that can examine
questions that pertain to radiographic correction as well as
preoperative, intraoperative, and postoperative factors.
In summary, we report the overall rate of VTE of 4.3% in an
ASDcohort.We report risk factors forVTE that are highly relevant
to deformity surgeons such as SVA correction and osteoporosis.
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